首页> 外文OA文献 >A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma

【2h】

A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma

机译：英国癌症研究第一次人类I期Ima950（新型多肽治疗性疫苗）在新诊断的胶质母细胞瘤患者中的试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Rampling, Roy; Peoples, Sharon; Mulholland, Paul J; James, Allan; Al-Salihi, Omar; Twelves, Christopher J; McBain, Catherine; Jefferies, Sarah; Jackson, Alan; Stewart, Willie; Lindner, Juha; Kutscher, Sarah; Hilf, Norbert; McGuigan, Lesley; Peters, Jane; Hill, Karen; Schoor, Oliver; Singh-Jasuja, Harpreet; Halford, Sarah E; Ritchie, James W A;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma [J] . Rampling Roy, Peoples Sharon, Mulholland Paul J., Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第19期

机译：一项癌症研究英国首次在新诊断为胶质母细胞瘤的患者中进行IMA950（新型多肽治疗疫苗）的人类I期试验
2. Phase Ⅰ/Ⅱ trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients [J] . Migliorini Denis, Dutoit Valerie, Allard Mathilde, Neuro-Oncology . 2019,第7期

机译：Ⅰ/Ⅱ期多肽IMA950 / poly-ICLC疫苗在初诊成人恶性星形细胞瘤患者中的安全性和免疫原性试验
3. Phase Ⅰ/Ⅱ trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients [J] . Migliorini Denis, Dutoit Valerie, Allard Mathilde, Neuro-Oncology . 2019,第7期

机译：在新诊断的成人恶性星形细胞瘤患者中，多肽IMA950 / Poly-ICLC疫苗的多肽IMA950 / Poly-ICLC疫苗的Ⅰ阶段Ⅰ/Ⅱ试验性和免疫原性
4. RISK-ADAPTED INTRAVENOUS MELPHALAN WITH ADJUVANT THALIDOMIDE AND DEXAMETHASONE FOR NEWLY DIAGNOSED UNTREATED PATIENTS WITH SYSTEMIC AL AMYLOIDOSIS: INTERIM REPORT OF A PHASE II TRIAL [C] . RL Comenzo, P Zhou, L Reich, International Symposium on Amyloidosis . 2005

机译：风险适应的静脉内莫尔甘蔗用佐剂沙利度胺和地塞米松，用于新诊断的未经治疗的全身淀粉样蛋白症患者：II期试验的中期报告
5. Race/Ethnic Disparities in Treatment Patterns among Newly Diagnosed Primary Prostate Cancer Patients in Florida [D] . Williams, Vonetta L. 2015

机译：佛罗里达州新诊断的原发性前列腺癌患者在治疗方式上的种族/种族差异
6. A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multi-Peptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma [O] . Roy Rampling, Sharon Peoples, Paul J. Mulholland, -1

机译：一项癌症研究英国首次在新诊断的胶质母细胞瘤患者中进行IMA950（新型多肽治疗疫苗）的人类I期试验
7. A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multi Peptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma. [O] . Rampling, R, Peoples, S, Mulholland, PJ, 2016

机译：英国癌症研究第一次在人类I期试验Ima950（新型多肽治疗性疫苗）用于新诊断的胶质母细胞瘤患者。

A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma

著录项

相似文献

相关主题

期刊订阅